COVID-19, CAMI and a new college: UArizona Health Sciences’ top 10 news releases of 2023 Dec. 19, 2023 UArizona Health Sciences made impactful contributions to health care and advanced major projects that are building a healthier future for Arizona and beyond. Read more Image
New data shows Black and Hispanic people less likely to get COVID vaccine Dec. 18, 2023 A new study, published in the American Journal of Public Health, shows that Hispanic and Black communities are hesitant to receive the COVID-19 vaccine. KAET-TV (Phoenix, AZ)
Call for proposals: Cancer Center Internal Pilot Awards Dec. 18, 2023 University of Arizona Cancer Center Read more
AZDHS reports a 20% increase in new HIV cases throughout the state Dec. 18, 2023 According to the Arizona Department of Health Services, there was a 20% rise in HIV cases in Arizona from 2021 to 2022. KOLD-TV (Tucson, AZ)
First dose administered in phase 1/2 clinical trial of OCU410, an emerging therapy for dry AMD Dec. 18, 2023 Biotech company Ocugen has started the ArMaDa Phase 1/2 clinical trial of OCU410, a modfier gene therapy product candidate being developed for dry age-related macular degeneration. Ophthalmology Times
Training and keeping primary care physicians in Arizona Dec. 14, 2023 The Primary Care Physician Scholarship program is educating a new generation of doctors, reducing debt and providing a path to practice in Arizona. Read more Thumbnail
Buckmaster Show 12/13/2023: Dealing with holiday stress Dec. 14, 2023 Victoria Maizes, MD, executive director of the Andrew Weil Center for Integrative Medicine in the College of Medicine – Tucson, is interviewed about topics including coping with holiday stress. KVOI-Radio (Tucson, AZ)
McCarthy + SmithGroup will develop UArizona’s CAMI Dec. 14, 2023 UArizona Health Sciences has selected the design-build team of McCarthy + SmithGroup to develop the Center for Advanced Molecular and Immunological Therapies, or CAMI. AZ Big Media
Pfizer stock plummets as people turn away from COVID boosters Dec. 14, 2023 Pfizer's stock dropped more than 44% in 2023, partly because fewer people than expected opted to receive COVID-19 booster shots. USSA News